• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

New Omicron Strain Demonstrates “Dramatic” Resistance To Antibody Immunity

October 17, 2022 by Deborah Bloomfield

An emerging Omicron subvariant has raised concerns about a surge of COVID-19 cases this winter, after it was found to display a worrying proclivity for evading vaccine immunity. BA.2.75.2, as it is called, can largely dodge neutralizing antibodies in the blood and is resistant to several monoclonal antibody treatments, new research from Sweden has discovered.

“While antibody immunity is not completely gone, BA.2.75.2 exhibited far more dramatic resistance than variants we’ve previously studied, largely driven by two mutations in the receptor binding domain of the spike protein,” said corresponding author Ben Murrell in a statement.

Advertisement

BA.2.75.2 is a sublineage of the Omicron variant and the latest mutant of subvariant BA.2.75, which is currently being monitored by the World Health Organization. Since its discovery earlier this fall, BA.2.75.2 has been reported in several countries, but thankfully only makes up a small number of total cases. At present, it accounts for just 1.4 percent of US cases, according to the Centers for Disease Control and Prevention.

The new study focused on three Omicron subvariants – BA.2.75.2, BA.4.6, and BA.2.10.4 – and used serum samples from 75 people taken at three different time points: November 2021, April 2022, and late August/early September of this year. 

“Across all three timepoints, neutralisation of BA.2.75.2 by serum antibodies was significantly lower than all other variants tested,” the authors write in their study.

Advertisement

In fact, the subvariant was found to be more than six times less responsive to neutralizing antibodies than the currently dominant variant, BA.5. This, the authors say, can be accounted for by two mutations, which contribute to its “significantly enhanced resistance”.

The researchers also tested the new subvariant’s susceptibility to a variety of monoclonal antibody treatments – antiviral treatments used for those at high risk of developing severe COVID-19. Only one of the treatments tested, bebtelovimab, was found to “potently” neutralize BA.2.75.2.

“We now know that this is just one of a constellation of emerging variants with similar mutations that will likely come to dominate in the near future,” Murrell added. “We should expect infections to increase this winter.”

Advertisement

However, whether or not this anticipated rise in infections will affect the number of hospitalizations remains unclear. It is also not known whether the updated COVID vaccines, modified to protect against early Omicron variants, will be able to protect against BA.2.75.2 and other emerging variants.

“We expect them to be beneficial, but we don’t yet know by how much,” Murrell said.

The study was published in The Lancet Infectious Diseases.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Sustainable jet fuel company Alder Fuels seals investments from United, Honeywell
  2. Migration not the solution to EU’s population challenge -CEE leaders
  3. Descendant of tsars becomes first royal to marry in Russia since revolution
  4. Are Air Fryers Actually Healthier And More Energy Efficient?

Source Link: New Omicron Strain Demonstrates "Dramatic" Resistance To Antibody Immunity

Filed Under: News

Primary Sidebar

  • Are There Body Parts You Can Live Without? Find Out More In Issue 37 Of CURIOUS – Out Now
  • New Study Unearths Humanity’s “Hidden” Crossings Out Of Africa
  • Trichonephila Clavipes: The Spider That Spins “Golden” Silk
  • The Southern Delta Aquariids And Alpha Capricornids Meteor Showers Will Dazzle The Skies Together Soon
  • Virus Found In Black-Eyed Pea Plants Could Be Used To Treat Cancer
  • Many People Have No Idea Where Oil Actually Comes From. It’s Not Dinosaurs
  • “World’s Rarest Elephant”: Meet Motty, The Only Known Elephant Hybrid
  • Missing 40 Percent Of Matter In The Universe Finally Discovered, Could We Be On Track For A Universal Cancer Vaccine, And Much More This Week
  • Solar Power Producing Heliostats Could Get A “Night Job” Finding Asteroids
  • COVID-19 Can Lead To Build Up Of Alzheimer’s-Linked Protein Clumps In Eyes And Brain
  • The Wild Life Of Snowflake, The Only Albino Gorilla Ever Known
  • Stunning Drone Footage Reveals Largest Turtle Nesting Site In The World, Containing 41,000 Females
  • New “Different Form” Of Type 1 Diabetes Found In Sub-Saharan African And Black American Patients
  • Neanderthals May Have Feasted On Maggots, Which They Harvested From Rotting Flesh
  • Common Cannabis Substitute May Be Far More Psychoactive Than Previously Thought
  • This Is The Most Bizarre International Border In The World
  • Earth Will Not Fall Into Darkness Next Week – But There Is An “Eclipse Of The Century” In 2027
  • 850,000-Year-Old Remains Suggest Prehistoric Child Was Decapitated And Eaten By Its Own Kind
  • How To Watch The ISS As It Crosses The US Night Sky In The Next Few Days
  • “Robo-Bunnies” Are Florida’s Newest Weapon Against Python Invaders
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version